Longitude Capital — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Venus develops non-invasive, energy-based medical aesthetic devices for body, face, skin, and hair treatments, integrating robotics, AI, and IoT technologies.
BiotechHardwareHealthtechMedical DevicesToronto, US
Domenic Serafino(Executive Officer, Director)Kirk Gunhus(Executive Officer)Ross Portaro(Executive Officer)Anna Georgiadis(Executive Officer)Melissa Kang(Executive Officer)Michael Mandarello(Executive Officer)
Board seatJuliet Bakker· per SEC Form D
Co-investorsAPERTURE Venture PartnersEssex Woodlands Healthcare PartnersClarusHealthQuest Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
